Test Code LAB1232584 Gastrointestinal Pathogen Panel, PCR, Feces
Useful For
Rapid detection of gastrointestinal infections caused by:
-Campylobacter species (Campylobacter jejuni/Campylobacter coli/Campylobacter upsaliensis)
-Clostridioides difficile toxin A/B
-Plesiomonas shigelloides
-Salmonella species
-Vibrio species (Vibrio parahaemolyticus, Vibrio vulnificus, Vibrio cholerae)
-Vibrio cholerae
-Yersinia species
-Enteroaggregative Escherichia coli (EAEC)
-Enteropathogenic E coli (EPEC)
-Enterotoxigenic E coli (ETEC)
-Shiga toxin
-E coli O157
-Shigella/Enteroinvasive E coli (EIEC)
-Cryptosporidium species
-Cyclospora cayetanensis
-Entamoeba histolytica
-Giardia
-Adenovirus F 40/41
-Astrovirus
-Norovirus GI/GII
-Rotavirus A
-Sapovirus
This test is not recommended as a test of cure.
Special Instructions
Reporting Name
GI Pathogen Panel, PCR, FSpecimen Type
FecalOrdering Guidance
It is not recommended that the following tests be concomitantly ordered if this test is ordered:
-VIBC / Vibrio Culture, Feces
-ROTA / Rotavirus Antigen, Feces
-LADV / Adenovirus, Molecular Detection, PCR, Varies
-GIAR / Giardia Antigen, Feces
-CRYPS / Cryptosporidium Antigen, Feces
-CYCL / Cyclospora Stain, Feces
-STL / Enteric Pathogens Culture, Feces
-CAMPC / Campylobacter Culture, Feces
-SHIGC / Shigella Culture, Feces
-SALMC / Salmonella Culture, Feces
-YERSC / Yersinia Culture, Feces
-E157C / Escherichia coli O157:H7 Culture, Feces
-STFRP / Shiga Toxin, Molecular Detection, PCR, Feces
-CDPCR / Clostridioides difficile Toxin, PCR, Feces
-LNORO / Norovirus PCR, Molecular Detection, Feces
Additional Testing Requirements
In some cases, there may be local public health requirements that impact Mayo Clinic Laboratories (MCL) clients and require additional testing on specimens with positive results from this panel. Clients should familiarize themselves with local requirements. MCL recommends clients retain an aliquot of each specimen submitted for this test to perform additional testing themselves, as needed. If necessary, see Interpretation for detailed information about how to obtain this testing.
Shipping Instructions
Specimen must arrive within 4 days of collection.
Do not freeze. Testing will be canceled on specimens received frozen.
Specimen Required
Supplies: Culture and Sensitivity Stool Transport Vial (T058)
Container/Tube:
Preferred: Specific modified Cary-Blair transport system; see Additional Information for acceptable collection media
Acceptable: Approved Cary-Blair transport system (15 mL of non-nutritive transport medium containing phenol red as a pH indicator)
Specimen Volume: Representative portion of feces
Collection Instructions:
1. Collect fresh fecal specimen and submit 1 gram or 5 mL in container with transport medium.
2. Within 2 hours of collection, place feces in preservative.
3. Submit preserved feces in original container. Do not aliquot.
4. If unpreserved specimens are received, testing will be canceled.
Additional Information:
If collection media other than those listed is utilized, testing may be canceled. Media listed have been verified for use by Mayo Clinic Laboratories.
Modified Cary-Blair media:
Preferred: Culture and Sensitivity Stool Transport Vial (T058)
Acceptable: Meridian Para-Pak C and S, Cardinal Health Culture and Sensitivity Stool transport Vial
Cary Blair media: Remel Cary-Blair, Remel; Protocol Cary-Blair
Specimen Minimum Volume
1 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Fecal | Ambient (preferred) | 4 days |
| Refrigerated | 4 days |
Reject Due To
| Unapproved commercial transport media (eg, AlphaTec Enteric Transport Medium [ETM], Para-Pak Enteric Plus, Medical Chemical Corporation C and S Transport Medium [MCC]) | Reject |
| Copan FecalSwab/ESwab | Reject |
| Products containing formalin (eg, Sodium Acetate-Acetic Acid Formalin fixative [SAF]; PolyVinyl Alcohol fixative [PVA]; EcoFix preservative | Reject |
| Swabs (eg, Cary-Blair gel swab; Rectal swab) | Reject |
| Stool swab; Gel swab | Reject |
| Endoscopy specimen | Reject |
| Unpreserved stool | Reject |
Reference Values
Negative (for all targets)
Supportive Data
The BioFire FilmArray Gastrointestinal Panel is a US Food and Drug Administration-cleared assay for testing Cary-Blair-preserved stool. A performance verification study of the FilmArray Gastrointestinal Panel was completed at Mayo Clinic (Rochester Minnesota).(1) Five hundred clinical stool specimens (retrospective/stored samples=270; prospective samples=230) were evaluated. Results were compared to a reference standard result, which was defined as an organism identified by routine culture, microscopy, or a consensus (2 out of 3) result obtained by molecular and/or antigen assays. Among 500 clinical stool samples, the assay showed greater than 90% agreement for all targets. Several targets, including Plesiomonas shigelloides, Cyclospora cayetanensis, Entamoeba histolytica, Vibrio species, and enterotoxigenic Escherichia coli did not have an adequate number of positive samples to rigorously assess the sensitivity of these targets.
To supplement the data derived from clinical samples, spiking studies were completed to evaluate the accuracy of all targets, including those that could not be analyzed by clinical specimens alone. This group included: Campylobacter species (n=4), Clostridioides difficile (n=4), Plesiomonas shigelloides (n=4), Salmonella species (n=4), Yersinia enterocolitica (n=4), Vibrio cholerae (n=4), enteroaggregative E coli (n=4), enteropathogenic E. coli (n=8), enterotoxigenic E coli (n=4), E coli O157 (n=4), Shigella species (n=8), Cryptosporidium species (n=4), Cyclospora cayetanensis (n=8), Entamoeba histolytica (n=4), Giardia lamblia (n=4), adenovirus 40/41 (n=4), norovirus (n=8), rotavirus A (n=4), sapovirus (n=4), and astrovirus (n=8). All targets demonstrated 100% agreement with the expected result during the spiking studies.
Method Description
The FilmArray GastrointestinaI Panel is a closed system that performs the chemistry required for isolation, amplification, and detection of nucleic acid from multiple viral, bacterial, and parasitic gastrointestinal pathogens from a single stool specimen of patients suspected to have a gastrointestinal infection. A panel contains reagents in freeze-dried form and is divided into discrete segments where the required chemical processes are carried out. Patient sample and hydration fluid are drawn by vacuum into the panel and then placed into the FilmArray instrument. The detection process operations are automated (nucleic acid purification, first-stage polymerase chain reaction [PCR], second-stage PCR, and melt analysis) and complete in about an hour in this closed system:
-Nucleic Acid Purification:
The sample is lysed by a combination of chemical and mechanical mechanisms and the liberated nucleic acid is captured, washed, and eluted using magnetic bead technology.
-First-Stage PCR:
A reverse transcription step is performed to convert viral RNA into complementary DNA prior to amplification. The purified nucleic acid solution is combined with a preheated master mix to initiate the reverse transcription step and subsequent thermocycling for multiplex PCR.
-Second-Stage PCR:
Products of first-stage PCR are diluted and mixed with fresh PCR reagents containing an intercalating fluorescent DNA dye, which is distributed over the second-stage PCR array. The individual wells of the array contain primers for different assays (in triplicate) that target specific nucleic acid sequences from each of the pathogens detected, as well as control template material.
-DNA Melting Analysis:
Temperature is slowly increased and fluorescence in each well of the array is monitored and analyzed to generate a melt curve.
-Analysis of Melt Curves:
The software evaluates the DNA melt curve for each well to determine if a PCR product was present in that well. If the melt profile indicates the presence of a PCR product, then the analysis software calculates the melting temperature of the curve, which is then compared against the expected range for the assay. When the software determines that the melt curve is positive and in range, it is called positive. When it determines that the melt curve is negative or is not in the appropriate range, it is called negative.
-Analysis of Replicates:
Melt curves of each of the 3 replicates for each assay are evaluated to determine the assay result. For an assay to be called positive, at least 2 of the 3 associated melt curves must be called positive, and the temperature for at least 2 of the 3 positive melt curves must be similar (within 1 degree C). Assays that do not meet these criteria are called negative.(Instruction manual: FilmArray Gastrointestinal [GI] Panel CE IVD. BioFire Diagnostics, LLC; RFIT-PRT-0143-05, 05/2021)
Specimen Retention Time
7 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
87507
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| GIP | GI Pathogen Panel, PCR, F | 82195-9 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| SRCGI | Specimen Source | 31208-2 |
| 37081 | Campylobacter species | 82196-7 |
| 37082 | C. difficile toxin | 82197-5 |
| 37083 | Plesiomonas shigelloides | 82198-3 |
| 37084 | Salmonella species | 82199-1 |
| 37085 | Vibrio species | 82200-7 |
| 37086 | Vibrio cholerae | 82201-5 |
| 37087 | Yersinia species | 82202-3 |
| 37088 | Enteroaggregative E. coli (EAEC) | 80349-4 |
| 37089 | Enteropathogenic E. coli (EPEC) | 80348-6 |
| 37090 | Enterotoxigenic E. coli (ETEC) | 80351-0 |
| 37091 | Shiga toxin producing E. coli | 82203-1 |
| 37092 | Escherichia coli O157 serotype | 82204-9 |
| 37093 | Shigella/Enteroinvasive E. coli | 80350-2 |
| 37094 | Cryptosporidium species | 82205-6 |
| 37095 | Cyclospora cayetanensis | 82206-4 |
| 37096 | Entamoeba histolytica | 82207-2 |
| 37097 | Giardia | 82208-0 |
| 37098 | Adenovirus F40/41 | 82209-8 |
| 37099 | Astrovirus | 82210-6 |
| 37100 | Norovirus GI/GII | 82211-4 |
| 37101 | Rotavirus | 82212-2 |
| 37103 | Sapovirus | 82213-0 |
| 37262 | Interpretation | 59464-8 |
Testing Algorithm
If positive for Vibrio species or Vibrio cholerae, a Vibrio culture will be performed at an additional charge.
The following algorithms are available:
Day(s) Performed
Monday through Sunday
Report Available
1 to 2 daysForms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-Gastroenterology and Hepatology Test Request (T728)
-Microbiology Test Request (T244)
Reflex Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| VIBC | Vibrio Culture, Stool | Yes | No |